What is the level of liabilities of BioArctic this year?
BioArctic has a debt balance of 216.74 M SEK this year.
BioArctic Liabilities 2025
BioArctic Liabilities
216.74 M SEK
Ticker
BIOA B.ST
ISIN
SE0010323311
WKN
A2H5GS
In 2025, BioArctic's total liabilities amounted to 216.74 M SEK, a 55.37% difference from the 139.5 M SEK total liabilities in the previous year.
BioArctic Aktienanalyse
What does BioArctic do?
BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing BioArctic's Liabilities
BioArctic's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating BioArctic's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing BioArctic's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
BioArctic's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in BioArctic’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about BioArctic stock
What were the liabilities of BioArctic compared to the previous year?
The liabilities of BioArctic have increased by 55.37% increased compared to the previous year.
What are the consequences of high debt for investors of BioArctic?
High liabilities can pose a risk for investors of BioArctic, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in BioArctic?
Low liabilities mean that BioArctic has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of BioArctic affect the company?
An increase in liabilities of BioArctic can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of BioArctic affect the company?
A decrease in the liabilities of BioArctic can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of BioArctic?
Some factors that can influence the liabilities of BioArctic include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of BioArctic so important for investors?
The liabilities of BioArctic are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can BioArctic take to modify the liabilities?
To change its liabilities, BioArctic can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does BioArctic pay?
Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.51 %. For the coming 12 months, BioArctic is expected to pay a dividend of 3.55 SEK.
What is the dividend yield of BioArctic?
The current dividend yield of BioArctic is 0.51 %.
When does BioArctic pay dividends?
BioArctic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioArctic?
BioArctic paid dividends every year for the past 5 years.
What is the dividend of BioArctic?
For the upcoming 12 months, dividends amounting to 3.55 SEK are expected. This corresponds to a dividend yield of 1.21 %.
In which sector is BioArctic located?
BioArctic is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.
When did BioArctic pay the last dividend?
The last dividend was paid out on 5/16/2019.
What was the dividend of BioArctic in the year 2024?
In the year 2024, BioArctic distributed 0 SEK as dividends.
In which currency does BioArctic pay out the dividend?
The dividends of BioArctic are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioArctic
Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
